The acute phase of HIV infection encompasses the interval immediately following viral acquisition, characterised by rapid viral replication, high plasma viraemia and the absence of a mature antibody ...
Acurx (ACXP) Pharmaceuticals announced updates on Phase 3 Readiness for Ibezapolstat in C. difficile Infection based on recent FDA and EMA communications. Acurx’s Executive Chairman, Bob DeLuccia, ...
STATEN ISLAND, N.Y., Dec. 9, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule ...
Researchers have identified new roles for a protein long known to protect against severe flu infection—among them, raising the minimum number of viral particles needed to cause sickness. The protein ...
Lyon, France – July 28, 2023 – Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses, today announced that The Lancet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results